Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600135084) titled 'Post-marketing study to assess the effectiveness and safety of RECARBRIO in Chinese adult patients with limited or no alternative treatment options for susceptible Gramnegative bacterial infections' on Oct. 23.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
Infections caused by sensitive Gram-negative bacteria for which there are limited drug options or no alternative treatments available
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-31
Target Sample Size: Observation group:140;
Countries of Rec...